Results 121 to 130 of about 6,415,892 (312)

Research Progress of Music Therapy on Gait Intervention in Patients with Parkinson’s Disease

open access: yes, 2022
Music therapy is an effective way to treat the gait disorders caused by Parkinson’s disease. Rhythm music stimulation, therapeutic singing, and therapeutic instrument performance are often used in clinical practice. The mechanisms of music therapy on the
Qiuxia Zhang   +8 more
core   +1 more source

Stage‐Dependent β‐Synuclein Links MRI and Cognitive Decline in Alzheimer's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Synaptic degeneration drives cognitive decline in Alzheimer's disease (AD), but synaptic biomarkers are scarce. Brain‐enriched β‐synuclein emerged as a synaptic damage marker. We investigated its diagnostic, prognostic, and structural correlates across the AD continuum.
Ulaş Ay   +15 more
wiley   +1 more source

Online cognitive monitoring technology for people with Parkinson’s disease and REM sleep behavioural disorder

open access: yesnpj Digital Medicine
Automated online cognitive assessments are set to revolutionise clinical research and healthcare. However, their applicability for Parkinson’s Disease (PD) and REM Sleep Behavioural Disorder (RBD), a strong PD precursor, is underexplored.
Maria Bălăeţ   +13 more
doaj   +1 more source

MOESM3 of A randomized controlled efficacy study of the Medido medication dispenser in Parkinsonâ s disease

open access: yes, 2019
Additional file 3. Table with secondary outcomes of UPDRS-4.
Hannink, K.   +8 more
openaire   +1 more source

Additional file 1: of The association between Parkinsonâ s disease and melanoma: a systematic review and meta-analysis

open access: yes, 2015
Characteristics of studies included in the Meta-analysis. Including information of first author, year of publication, country, study design, number of patients and controls, duration of follow-up. (PDF 74 kb)
Huang, Pei   +3 more
openaire   +1 more source

Data‐Driven SuStaIn Model of Disability Progression in Amyotrophic Lateral Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether ordinal Subtype and Stage Inference (SuStaIn) applied to routine ALSFRS‐R item scores can identify reproducible disability progression patterns in amyotrophic lateral sclerosis (ALS) and provide clinically meaningful staging.
Giammarco Milella   +5 more
wiley   +1 more source

A case of neuroleptic malignant syndrome on withdrawal of benzhexol [PDF]

open access: yes, 2010
The neuroleptic malignant syndrome is a rare and potentially lethal reaction which is usually associated with the use of medications with antidopaminergic properties.
Ferry, Peter   +2 more
core  

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2024 Update [PDF]

open access: yes
Background: For the past five years, our annual reports have been tracking the clinical development of new drug-based therapies for the neurodegenerative condition of Parkinson’s disease (PD). These reviews have followed the progress both of “symptomatic
Buff, S   +10 more
core   +1 more source

Alzheimer's Disease Biomarkers Measured by Capillary Blood Collection Versus Venous Plasma and Cerebrospinal Fluid

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Blood biomarkers are increasingly critical for non‐invasive Alzheimer's Disease (AD) diagnostics and research but typically require on‐site processing. Remote point‐of‐care collection methods could enhance biomarker testing in clinical and research settings.
Sara Ho   +9 more
wiley   +1 more source

Additional file 1: of Recent advances in rehabilitation for Parkinsonâ s Disease with Exergames: A Systematic Review

open access: yes, 2019
Table S1. Overview of the selected RCTs and Pilot Studies (PDF 276 kb)
Garcia-Agundez, Augusto   +7 more
openaire   +1 more source

Home - About - Disclaimer - Privacy